Patents expiring in 2037

US 9550837

Therapeutic uses of anti-PCSK9 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9551721

Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases

The Board of Regents of the University of Texas System · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9551722

Amyloid binding agents

The Regents of the University of California · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550988

Antisense compounds

Ionis Pharmaceuticals, Inc. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550994

RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

Arrowhead Pharmaceuticals, Inc. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550827

Methods for ameliorating and preventing central nervous system inflammation

The Regents of the University of California · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9551003

Increasing levels of nicotinic alkaloids in plants

22ND CENTURY LIMITED, LLC · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550775

Substituted triazolopyridines and methods of use thereof

Xenon Pharmaceuticals Inc. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550761

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550757

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9551713

Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer

The Board of Regents of the University of Texas System · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550742

11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550078

EDAR ligand derived peptides and use thereof

CAREGEN CO., LTD. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550974

Derivation of embryonic stem cells

Astellas Institute for Regenerative Medicine · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549954

Method and composition for inducing human pluripotent stem cells

The Regents of the University of California · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550002

Phospholipid analogs as diapeutic agents and methods thereof

CELLECTAR BIOSCIENCES, INC. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549995

Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy

The Board of Regents of the University of Texas System · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550756

Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

Takeda Pharmaceutical Company Limited · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549955

Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549943

A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

CAN-FITE BIOPHARMA LTD. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549934

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

Almirall, S.A. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549940

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9549913

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9550818

Methods for use of vascular endothelial growth factor antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2017020867

USE OF MASITINIB FOR THE TREATMENT OF CROHN'S DISEASE

AB SCIENCE [FR] · Granted Thu Jan 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2017013210

TRAITEMENT ET PRÉVENTION DE MALADIES VIRALES AVEC DES COMPOSÉS DE 2,3-DIHYDROBENZOFURAN-5-YL

4SC AG [DE] · Granted Thu Jan 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555099

Vaccines for HSV-2

IMMUNE DESIGN CORP. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555086

Compositions and methods for inducing an immune response

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555074

Annexin II compositions

Regents of the University of Minnesota · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555073

Use of vitelline protein B as a microencapsulating additive

The Regents of the University of California · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555064

Protease-deficient Bacillus anthracis

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555017

Methods of making a mixture of salts of gamma-hydroxybutyrate

Jazz Pharmaceuticals Ireland Limited · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555037

Method of using vasoconstrictive agents during energy-based tissue therapy

Covidien LP · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555016

Lytic agents for use in treating intravascular clots

Covidien LP · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555004

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9554587

Anti-regurgitation composition maintaining gut motility

UNITED PHARMACEUTICALS · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9554563

Genetically modified mice and engraftment

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9554999

Lyophilization of synthetic liposomal pulmonary surfactant

Windtree Therapeutics, Inc. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555112

Monoclonal antibodies against HER2 epitope and methods of use thereof

Mersana Therapeutics, Inc. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9554987

Methods and formulations for treating sialic acid deficiencies

Ultragenyx Pharmaceutical Inc. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555041

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555090

Equine encephalitis virus vaccines and methods of using thereof

The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555100

Herpes virus vaccine and methods of use

The Regents of the University of California · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9556113

Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment

SOUTH DAKOTA BOARD OF REGENTS · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9556244

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555135

Cobalt-based MRI contrast agent and imaging system

The Board of Regents of the University of Texas System · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555114

Methods for in vivo drug delivery with porous nanostructures

The Regents of the University of California · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9556232

Anti-angiogenic molecules, nanostructures and uses thereof

Northwestern University · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)